Literature DB >> 22543032

3-Monoglucuronyl-glycyrrhretinic acid is a substrate of organic anion transporters expressed in tubular epithelial cells and plays important roles in licorice-induced pseudoaldosteronism by inhibiting 11β-hydroxysteroid dehydrogenase 2.

Toshiaki Makino1, Kyoko Okajima, Rie Uebayashi, Nobuhiro Ohtake, Katsuhisa Inoue, Hajime Mizukami.   

Abstract

Licorice (glycyrrhiza root) has been used as a herbal medicine worldwide with its main active constituent being glycyrrhizin (GL). Licorice sometimes causes adverse effects such as inducing pseudoaldosteronism by inhibiting type 2 11β-hydroxysteroid dehydrogenase (11β-HSD2) caused by glycyrrhetinic acid (GA), a major metabolite of GL. In this study we compared the inhibitory effects of GA, GL, and 3-monoglucuronyl-glycyrrhetinic acid (3MGA), another metabolite of GL, on 11β-HSD2 activity by using microsomes and rat kidney tissue slices. GA, 3MGA, and GL inhibited 11β-HSD2 in rat kidney microsomes, with IC(50) values of 0.32, 0.26, and 2.2 μM, respectively. However, the inhibitory activity of these compounds was reduced markedly, in the slices, in a medium containing 5% bovine serum albumin. Assays using human embryonic kidney 293 cells with transient transformation in transporter genes showed that 3MGA is a substrate of human organic anion transporter (OAT) 1, human OAT3, and human organic anion-transporting peptide 4C1, whereas GA is not. When GA (100 mg/kg/day) was administered orally for 16 days to Eisai hyperbilirubinemic rats, plasma concentrations and urinary excretion of 3MGA were significantly higher, whereas the activity of 11β-HSD2 in kidney microsomes was significantly lower compared with Sprague Dawley rats. These results suggest that 3MGA is actively transported into tubules through OATs, resulting in the inhibition of 11β-HSD2. Because the plasma level of 3MGA depends on the function of hepatic transporters, monitoring 3MGA levels in plasma or urine may be useful for preventing pseudoaldosteronism when licorice or GL is prescribed to patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22543032     DOI: 10.1124/jpet.111.190009

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  14 in total

Review 1.  Renal organic anion transporters (SLC22 family): expression, regulation, roles in toxicity, and impact on injury and disease.

Authors:  Li Wang; Douglas H Sweet
Journal:  AAPS J       Date:  2012-10-09       Impact factor: 4.009

Review 2.  Renal Drug Transporters and Drug Interactions.

Authors:  Anton Ivanyuk; Françoise Livio; Jérôme Biollaz; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2017-08       Impact factor: 6.447

3.  Glycyrrhizin has a high likelihood to be a victim of drug-drug interactions mediated by hepatic organic anion-transporting polypeptide 1B1/1B3.

Authors:  Jiajia Dong; Olajide E Olaleye; Rongrong Jiang; Jing Li; Chuang Lu; Feifei Du; Fang Xu; Junling Yang; Fengqing Wang; Weiwei Jia; Chuan Li
Journal:  Br J Pharmacol       Date:  2018-07-23       Impact factor: 8.739

4.  18α-Glycyrrhetinic acid monoglucuronide as an anti-inflammatory agent through suppression of the NF-κB and MAPK signaling pathway.

Authors:  Bo Li; Yongan Yang; Liuzeng Chen; Shichao Chen; Jing Zhang; Wenjian Tang
Journal:  Medchemcomm       Date:  2017-06-02       Impact factor: 3.597

Review 5.  Research progress on the protective effects of licorice-derived 18β-glycyrrhetinic acid against liver injury.

Authors:  Shou-Yan Wu; Wen-Jie Wang; Jin-Hui Dou; Li-Kun Gong
Journal:  Acta Pharmacol Sin       Date:  2020-03-06       Impact factor: 6.150

6.  A semi-physiologically based pharmacokinetic pharmacodynamic model for glycyrrhizin-induced pseudoaldosteronism and prediction of the dose limit causing hypokalemia in a virtual elderly population.

Authors:  Ruijuan Xu; Xiaoquan Liu; Jin Yang
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

7.  Identification of an Alternative Glycyrrhizin Metabolite Causing Liquorice-Induced Pseudohyperaldosteronism and the Development of ELISA System to Detect the Predictive Biomarker.

Authors:  Kan'ichiro Ishiuchi; Osamu Morinaga; Tetsuhiro Yoshino; Miaki Mitamura; Asuka Hirasawa; Yasuhito Maki; Yuuna Tashita; Tsubasa Kondo; Kakuyou Ogawa; Fangyi Lian; Keiko Ogawa-Ochiai; Kiyoshi Minamizawa; Takao Namiki; Masaru Mimura; Kenji Watanabe; Toshiaki Makino
Journal:  Front Pharmacol       Date:  2021-05-17       Impact factor: 5.810

Review 8.  Integrative veterinary medical education and consensus guidelines for an integrative veterinary medicine curriculum within veterinary colleges.

Authors:  M A Memon; J Shmalberg; H S Adair; S Allweiler; J N Bryan; S Cantwell; E Carr; C Chrisman; C M Egger; S Greene; K K Haussler; B Hershey; G R Holyoak; M Johnson; S Le Jeune; A Looney; R S McConnico; C Medina; A J Morton; A Munsterman; G J Nie; N Park; M Parsons-Doherty; J A Perdrizet; J L Peyton; D Raditic; H P Ramirez; J Saik; S Robertson; M Sleeper; J Van Dyke; J Wakshlag
Journal:  Open Vet J       Date:  2016-03-28

9.  Isolation of a novel glycyrrhizin metabolite as a causal candidate compound for pseudoaldosteronism.

Authors:  Osamu Morinaga; Kan'ichiro Ishiuchi; Takeshi Ohkita; Chuanting Tian; Asuka Hirasawa; Miaki Mitamura; Yasuhito Maki; Tomoya Yasujima; Hiroaki Yuasa; Toshiaki Makino
Journal:  Sci Rep       Date:  2018-10-22       Impact factor: 4.379

Review 10.  An Overview of Structurally Modified Glycyrrhetinic Acid Derivatives as Antitumor Agents.

Authors:  Bing Xu; Gao-Rong Wu; Xin-Yu Zhang; Meng-Meng Yan; Rui Zhao; Nan-Nan Xue; Kang Fang; Hui Wang; Meng Chen; Wen-Bo Guo; Peng-Long Wang; Hai-Min Lei
Journal:  Molecules       Date:  2017-06-02       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.